Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 05 Apr 2023
Being ill frequently may slow down brain aging and raise the risk of dementia and other forms of cognitive decline.
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
In a discrete choice experiment, somnolence risk and short-term efficacy were the top factors driving vesicular monoamine transporter 2 inhibitor selection for tardive dyskinesia in patients aged 55 years and older.
FDA approves once-daily oral tavapadon for Parkinson disease, a first-in-class D1/D5 partial agonist that improves motor function and ON time, with key safety warnings.
New PREVAIL trial analyses presented at the 2026 AANEM Annual Meeting showed gefurulimab reduced gMG-related hospitalizations and produced durable symptom and quality-of-life gains through one year.
PridCor Therapeutics is moving its phase 2 SHIELD trial of a combination antiviral regimen toward enrollment, building on case series data showing durable symptom improvement in long COVID.
New phase 3 MINT trial analyses presented at the 2026 AANEM Annual Meeting showed inebilizumab produced sustained improvement in MuSK-positive gMG regardless of time since diagnosis.
A joint ESC/ERA guideline on universal CKD screening headlines August 2026's nephrology news, alongside new finerenone and sibeprenlimab trial data.
1.
Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.
2.
Daily physical activity, even at light intensities, linked to lower cancer risk
3.
Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.
4.
How to keep your prostate healthy and lower your risk of developing serious problems
5.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
1.
Novel Immune Agonists for Cancer: Mechanisms, Clinical Impact, and Future Directions
2.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
3.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
4.
Understanding Sideroblastic Anemia and its Symptoms
5.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
Recognizing the Signs of Anemia in Adults
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
How Cancer Screening Supports Early Diagnosis
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge